跳至主要内容
临床试验/NCT00739440
NCT00739440已完成4 期

Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.0 个研究点目标入组 120 人开始时间: 2008年8月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120
主要终点
Resolution of signs and symptoms of scorpion envenomation

研究概览

简要总结

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

详细描述

We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem.

This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Sting scorpion
  • Informed consent
  • Age 15-60
  • Either sex
  • Resident in study area

排除标准

  • Previous treatment with gammaglobulin
  • Blood transfusion at any stage of life
  • Sensitivity or intolerance to serums antiscorpion or horse products
  • Pregnancy
  • Some immunodeficiency

结局指标

主要结局

Resolution of signs and symptoms of scorpion envenomation

时间窗: after treatment (expected average of 12 hrs)

次要结局

  • Evaluate the adverse events in every treated child(inmediately after treatment and until 5 days later)

研究者

发起方
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
申办方类型
Other
责任方
Sponsor

相似试验